Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
03/2007
03/28/2007EP1765823A1 Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
03/28/2007EP1765409A2 Conjugates of antibody and duocarmycin derivatives as antitumor agents
03/28/2007EP1765354A1 Leptomycin compounds
03/28/2007EP1575956B1 Fungicides based on nitrogen-containing heterocycles
03/28/2007EP1453836B1 BICYCLIC [1,2,4] -TRIAZOLE ADENOSINE A2a RECEPTOR ANTAGONISTS
03/28/2007EP1228071B1 Pharmaceutically active isoindoline derivatives
03/28/2007EP0988305B1 A PROCESS FOR THE PREPARATION OF 5H,9bH-2a, 4a,7,9a-OCTAHYDROTETRAAZACYCLOOCTA [cd] PENTALENE
03/28/2007CN1938313A 6-(2-fluorophenyl)-triazolopyrimidines, method for producing them, their use for controlling parasitic fungi and agents containing the same
03/28/2007CN1938312A 6-(2,6-dichlorophenyl)-triazolopyrimidines, methods for the production thereof, use thereof for controlling pathogenic fungi, and agents containing the same
03/28/2007CN1938311A Macrocyclic compounds as inhibitors of viral replication
03/28/2007CN1938310A Imidazo 1,2-c pyrimidinylacetic acid derivatives
03/28/2007CN1938309A Crf receptor antagonists and methods relating thereto
03/28/2007CN1938308A Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
03/28/2007CN1938306A Crystalline forms of 5, 11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6h-dipyrido[3,2-b:2',3'-e] [1,4]diazepin-6-one
03/28/2007CN1938296A Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists
03/28/2007CN1938244A Fluoridation method
03/28/2007CN1937921A 5,6-cycloalkyl-7-aminotriazolopyrimidines, method for production and use thereof for the prevention of fungal pests and agents comprising the same
03/28/2007CN1935829A Nucleic acid hydrolysis cutting agent based on cucurbituril
03/28/2007CN1307181C Condensed heterocyclic succimide compounds as androgen receptor modulators and their analog
03/28/2007CN1307179C Pyrimidine derivatives for inhibition of cell proliferation
03/28/2007CN1307178C Novel tricyclic pyridyl benzazepine carboxyamides and derivatives their tocolytic oxytocin leceptor antagonists
03/28/2007CN1307174C Imidazoquinoline derivatives
03/28/2007CN1307159C TNF-alpha prodn. inhibitors
03/27/2007US7196364 Molecular device, molecule array, rectifier device, rectifying method, sensor device, switching device, circuit device, logical circuit device, operational device and information processing device
03/27/2007US7196111 Pyrazolo[1,5a]pyrimidine compounds as antiviral agents
03/27/2007US7196103 Indole derivatives as factor Xa inhibitors
03/27/2007US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion
03/27/2007US7196101 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (IgE) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases
03/27/2007US7196095 anti-protoazoal; poultry feed; therapy for cytokine mediated disease i.e. osteoarthritis, cerebral malaria, chronic pulmonary inflammatory disease, silicosis, pulmonary sarcosis, bone resorption diseases, reperfusion injury, graft v. host rejection
03/27/2007US7196094 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
03/27/2007US7196093 For prophylaxis and therapy of hemorrhagic virus infection, autoimmune diseases, autograft rejection, neoplasm, hyperhomocysteineuria, cardiovascular disease, stroke, Alzheimer's disease, or diabetes; can be used in combination with an anti-hemorrhagic viral infection agent, an immunosuppressant
03/27/2007US7196092 N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
03/27/2007US7196090 Nitrogen compounds such as 1-cyclopentyl-3-(2,6-difluoro-3,5-dimethoxy-phenyl)-7-(4-dimethylamino -butylamino)-1H-pyrimido (4,5-d)pyrimidin-2-one used as cyclin-dependent and tyrosine kinase enzymes inhibitors; anticarcinogenic agents
03/27/2007US7196085 Phthalazinone derivatives
03/27/2007US7196083 Antiproliferative or anticarcinogenic agents comprising reaction products of ninhydrin or benzo(f)ninhydrin with 1,5-diaminotetrazole; enzyme inhibitors
03/27/2007US7196080 Respiratory system disordeers; chronic obstructive pulminary disease
03/27/2007US7196078 Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors
03/27/2007US7196076 Androgen receptor modulators and methods of use thereof
03/27/2007CA2378002C Method for preparing 2-(2-arylmorpholin-2-yl)ethanol derivatives and intermediates
03/27/2007CA2326611C Substituted heterocyclic derivatives
03/27/2007CA2169145C Substituted benzisoxazole and benzisothiazole herbicidal agents
03/22/2007WO2007033175A1 Indolobenzazepine hcv ns5b inhibitors
03/22/2007WO2007033080A2 Alzheimer's disease imaging agents
03/22/2007WO2007033032A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
03/22/2007WO2007032936A2 Azafused cyclin dependent kinase inhibitors
03/22/2007WO2007031739A1 Heterobicyclic compounds as glucokinase activators
03/22/2007WO2007000655A3 Novel pyrazolopyrimidinone derivatives
03/22/2007WO2006070244A3 A process for the preparation of zaleplon
03/22/2007US20070066818 Method for preparing cucurbiturils
03/22/2007US20070066676 2-(2,3,3a,8b-Tetrahydro-1H-cyclopenta[b]indol-4-yl-substituted acetamides, acetonitriles and ethylamines as intermediates
03/22/2007US20070066632 Fused bicyclic inhibitors of TGFbeta
03/22/2007US20070066621 Novel 4-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo[1,5-a]pyridines, pyrazolo[1,5-c]pyrimidines and 2h-indazole compounds and 5-cyano, 5-amino, and 5-aminomethyl derivatives of imidazo[1,2-a]pyridines, and imidazo[1,5-a]pyrazines as cyclin dependent kinase inhibitors
03/22/2007US20070066620 central nervous system disorders including movement disorders, Extra Pyramidal Syndrome; compounds can be use with other agents useful in treating Parkinson's disease
03/22/2007US20070066619 Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity
03/22/2007US20070066605 Fungicides
03/22/2007US20070066600 Compounds
03/22/2007US20070066599 New compounds
03/22/2007US20070066598 Compounds
03/22/2007US20070066592 5-{6-[(3R)-1-azabicyclo[2.2.2]oct-3-yloxy]pyridazin-3-yl}-1H-indole; attention deficit disorder, attention deficit hyperactivity disorder, Alzheimer's disease, senile dementia, AIDS dementia, Pick's Disease, dementia associated with Down's syndrome; alpha 7 nAChR ligands modulators
03/22/2007US20070066586 Aniline derivatives
03/22/2007US20070066575 Methods and compositions for mitigating pain
03/22/2007US20070066513 photosensitizers used in the photodynamic therapy of microbial infections, tumors, pre-cancerous and proliferative pathologies and/or in the diagnosis, as well as for blood and blood derivatives sterilization
03/22/2007US20070066488 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics
03/22/2007US20070065826 Cationic dye compound for detecting nucleic acid double strand, and detection method and apparatus using same
03/22/2007DE4221599B4 Elektrophotographisches Aufzeichnungsmaterial An electrophotographic recording material
03/22/2007CA2621983A1 Azafused cyclin dependent kinase inhibitors
03/21/2007EP1764082A2 4-5-diamino-N,N-dihydro-pyrazol-3-one derivatives for use in composition for dyeing keratin fibres
03/21/2007EP1763530A1 Imidazopyridazine diones, the production thereof, and the use of the same as a medicament
03/21/2007EP1763524A1 Indole derivatives and use thereof as kinase inhibitors
03/21/2007EP1763514A2 Cycloalkyl substituted pyrimidinediamine compounds and their uses
03/21/2007EP1425282B1 Process for the preparation of diketopyrrolopyrroles
03/21/2007EP1414302B1 7-amino triazolopyrimidines for controlling harmful fungi
03/21/2007CN1934115A Diastereoselective epoxidation of allylically substituted alkenes using metalloporphyrin catalysts
03/21/2007CN1934114A Substituted sym-triindole
03/21/2007CN1934113A Compositions useful as inhibitors of protein kinases
03/21/2007CN1934112A Fused hetrocyclic compounds and their use as metabotropic receptor antagonists
03/21/2007CN1934111A Heteroaryl-fused pyrazolo derivatives
03/21/2007CN1934101A Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
03/21/2007CN1934091A Imidazole compounds for the treatment of neurodegenerative disorders
03/21/2007CN1933839A Compounds and methods of use
03/21/2007CN1931859A New fused imidazole derivative
03/21/2007CN1305871C Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders
03/20/2007US7193237 Organic semiconductor material and organic electronic device
03/20/2007US7193080 Color photography
03/20/2007US7193079 Reacting 2-carboxamidoethyl-Indolecarboxylic acid compound with methyl sulfonic acid and phosphorus pentoxide, reacting resulting indoloazepine compound with phenyl oxazolone and a transition metal catalyst, reacting resulting compound with with thiourea and a base in a solvent
03/20/2007US7192969 Ester derivatives
03/20/2007US7192968 Ethylenediamine derivatives
03/20/2007US7192967 Cyclic imide-substituted pyridylalkane, alkene, alkine carboxamides useful as cytostatic and immunosuppressive agents
03/20/2007US7192963 Janus Kinase 3 inhibitors; organ transplant rejection, xeno transplation, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukemia, and autoimmune diseases
03/20/2007US7192949 Anticarcinogenic and antiproliferative agents
03/20/2007US7192948 Bicyclic heterocycles as HIV integrase inhibitors
03/20/2007US7192650 Photoelectric conversion; efficiency, reduced energy loss
03/20/2007US7192452 Pyrazolo(3,2-c)-1,2,4- triazoles generate intense colorations in a variety of shades, and have a coloration which scarcely varies during a deferred application.
03/20/2007CA2162154C Use of a transition metal complex for the treatment of septic shock
03/20/2007CA2142280C Metal-mediated cross-coupling with ring-metalated porphyrins
03/15/2007WO2007030061A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases
03/15/2007WO2007029806A1 Azaaromatic compounds having azafluoranthene skeletons and organic electroluminescent devices made by using the same
03/15/2007WO2007029078A2 Succinimide and glutarimide derivatives as adrenergic receptor antagonists
03/15/2007WO2007029037A2 Class iia histone deacetylase (hdac) substrate
03/15/2007WO2007029035A2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors